PubMed · 15237921
Proteomics and chronic inflammatory bowel diseases.
Abstract
Inflammatory bowel diseases (IBD) are relatively frequent in developed countries. Physiopathological events involved in the etiology of IBDs include activation of immune, mesenchymal and epithelial cells. This review gives an overview of the currently applied proteomics technologies. It describes metabolic changes and goes into the approaches using this methodology to understand the molecular mechanisms implicated in the development of the disease.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Emanuela Felley-Bosco, Muriel André. 2004. Proteomics and chronic inflammatory bowel diseases.. https://doi.org/10.1016/j.prp.2004.02.002
Cite the original work for its findings. Save a collection to share your selection of sources.